Robert (“Bob”) W. Azelby
Board Member
Autolus Therapeutics plc (AUTL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert (“Bob”) W. Azelby
Robert (“Bob”) W. Azelby is recorded as Board Member at Autolus Therapeutics plc (AUTL). Autolus Therapeutics plc reported in an 8-K filed January 10, 2024 that Robert (“Bob”) W. Azelby was appointed Class II director, effective January 9, 2024.
“the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Robert (“Bob”) W. Azelby to serve as a Class II director of the Company, effective January 9, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Autolus Therapeutics plc
Other people whose current roles at this company are on record from its filings.
- Michael W. Bonney Chairman, Board Member
- Patrick McIlvenny Chief Accounting Officer
- Rob Dolski Chief Accounting Officer
- Elisabeth ("Lis") Leiderman, M.D. Board Member
- Ravi M. Rao Board Member
- Ryan Richardson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.